rs397514495
|
|
Neoplastic Syndromes, Hereditary
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance Imaging.
|
28772290 |
2017 |
rs397514495
|
|
Neoplastic Syndromes, Hereditary
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
|
28767289 |
2017 |
rs397514495
|
|
Neoplastic Syndromes, Hereditary
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
|
28724667 |
2017 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
|
27101868 |
2016 |
rs397514495
|
|
LI-FRAUMENI SYNDROME 1
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
|
26484312 |
2015 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Integrative clinical genomics of advanced prostate cancer.
|
26000489 |
2015 |
rs397514495
|
|
LI-FRAUMENI SYNDROME 1
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
|
25186627 |
2015 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
|
24797764 |
2014 |
rs397514495
|
|
LI-FRAUMENI SYNDROME 1
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.
|
24556621 |
2014 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
|
0.800 |
GeneticVariation
|
UNIPROT |
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
|
24493721 |
2014 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
CausalMutation
|
CLINVAR |
Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
|
23175693 |
2013 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
|
23175693 |
2013 |
rs397514495
|
|
LI-FRAUMENI SYNDROME 1
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
|
23175693 |
2013 |
rs397514495
|
|
Neoplastic Syndromes, Hereditary
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
|
23175693 |
2013 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
CausalMutation
|
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs397514495
|
|
LI-FRAUMENI SYNDROME 1
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs397514495
|
|
Neoplastic Syndromes, Hereditary
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.
|
21343334 |
2011 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
CausalMutation
|
CLINVAR |
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
|
21059199 |
2010 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
|
21059199 |
2010 |
rs397514495
|
|
LI-FRAUMENI SYNDROME 1
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
|
21059199 |
2010 |
rs397514495
|
|
Neoplastic Syndromes, Hereditary
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
|
21059199 |
2010 |
rs397514495
|
|
Neoplastic Syndromes, Hereditary
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.
|
20471942 |
2010 |
rs397514495
|
|
LI-FRAUMENI SYNDROME 1
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.
|
20471942 |
2010 |
rs397514495
|
|
Li-Fraumeni Syndrome
|
T |
0.800 |
GeneticVariation
|
CLINVAR |
Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation.
|
20128691 |
2010 |